Literature DB >> 21924349

Going out of the brain: non-nervous system physiological and pathological functions of Cdk5.

Erick Contreras-Vallejos1, Elias Utreras, Christian Gonzalez-Billault.   

Abstract

Cyclin-dependent kinase 5 (Cdk5) is a proline-directed serine/threonine kinase that is mostly active in the nervous system, where it regulates several processes such as neuronal migration, actin and microtubule dynamics, axonal guidance, and synaptic plasticity, among other processes. In addition to these known functions, in the past few years, novel roles for Cdk5 outside of the nervous system have been proposed. These include roles in gene transcription, vesicular transport, apoptosis, cell adhesion, and migration in many cell types and tissues such as pancreatic cells, muscle cells, neutrophils, and others. In this review, we will summarize the recently studied non-neuronal functions of Cdk5, with a thorough analysis of the biological consequences of these novel roles. Copyright Â
© 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21924349     DOI: 10.1016/j.cellsig.2011.08.022

Source DB:  PubMed          Journal:  Cell Signal        ISSN: 0898-6568            Impact factor:   4.315


  54 in total

1.  Identification and characterization of a novel phosphoregulatory site on cyclin-dependent kinase 5.

Authors:  Brett Lee Roach; Jordan Matthew Ngo; Clariss Limso; Koyinsola Bolutife Oloja; Deepali Bhandari
Journal:  Biochem Biophys Res Commun       Date:  2018-09-11       Impact factor: 3.575

2.  The NAD-dependent deacetylase sirtuin 2 is a suppressor of microglial activation and brain inflammation.

Authors:  Teresa Faria Pais; Éva M Szegő; Oldriska Marques; Leonor Miller-Fleming; Pedro Antas; Patrícia Guerreiro; Rita Machado de Oliveira; Burcu Kasapoglu; Tiago Fleming Outeiro
Journal:  EMBO J       Date:  2013-09-06       Impact factor: 11.598

3.  Heat shock inhibition of CDK5 increases NOXA levels through miR-23a repression.

Authors:  Trevor M Morey; Rabih Roufayel; Donald S Johnston; Andrew S Fletcher; Dick D Mosser
Journal:  J Biol Chem       Date:  2015-03-31       Impact factor: 5.157

4.  Cdk5 regulates Rap1 activity.

Authors:  Elias Utreras; Daniel Henriquez; Erick Contreras-Vallejos; Cristina Olmos; Alex Di Genova; Alejandro Maass; Ashok B Kulkarni; Christian Gonzalez-Billault
Journal:  Neurochem Int       Date:  2013-02-13       Impact factor: 3.921

5.  Role of CDK5/cyclin complexes in ischemia-induced death and survival of renal tubular cells.

Authors:  Tatiana Guevara; Mónica Sancho; Enrique Pérez-Payá; Mar Orzáez
Journal:  Cell Cycle       Date:  2014-03-25       Impact factor: 4.534

6.  Identification of unique MEK-dependent genes in GNAQ mutant uveal melanoma involved in cell growth, tumor cell invasion, and MEK resistance.

Authors:  Grazia Ambrosini; Christine A Pratilas; Li-Xuan Qin; Madhavi Tadi; Oliver Surriga; Richard D Carvajal; Gary K Schwartz
Journal:  Clin Cancer Res       Date:  2012-05-01       Impact factor: 12.531

7.  The Activators of Cyclin-Dependent Kinase 5 p35 and p39 Are Essential for Oligodendrocyte Maturation, Process Formation, and Myelination.

Authors:  Fucheng Luo; Jessie Zhang; Kathryn Burke; Robert H Miller; Yan Yang
Journal:  J Neurosci       Date:  2016-03-09       Impact factor: 6.167

8.  Proteomic analysis of the human cyclin-dependent kinase family reveals a novel CDK5 complex involved in cell growth and migration.

Authors:  Shuangbing Xu; Xu Li; Zihua Gong; Wenqi Wang; Yujing Li; Binoj Chandrasekharan Nair; Hailong Piao; Kunyu Yang; Gang Wu; Junjie Chen
Journal:  Mol Cell Proteomics       Date:  2014-08-05       Impact factor: 5.911

9.  Cdk5 disruption attenuates tumor PD-L1 expression and promotes antitumor immunity.

Authors:  R Dixon Dorand; Joseph Nthale; Jay T Myers; Deborah S Barkauskas; Stefanie Avril; Steven M Chirieleison; Tej K Pareek; Derek W Abbott; Duncan S Stearns; John J Letterio; Alex Y Huang; Agne Petrosiute
Journal:  Science       Date:  2016-07-21       Impact factor: 47.728

10.  Cdk5 promotes DNA replication stress checkpoint activation through RPA-32 phosphorylation, and impacts on metastasis free survival in breast cancer patients.

Authors:  Sara Chiker; Vincent Pennaneach; Damarys Loew; Florent Dingli; Denis Biard; Fabrice P Cordelières; Simon Gemble; Sophie Vacher; Ivan Bieche; Janet Hall; Marie Fernet
Journal:  Cell Cycle       Date:  2015       Impact factor: 4.534

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.